x
Breaking News
More () »

FDA expected to greenlight first-of-its-kind Alzheimer's drug

The FDA is expected to soon greenlight a first-of-its-kind drug to treat Alzheimer's. Dr. James Leverenz of the Cleveland Clinic joins us to discuss the latest.

Before You Leave, Check This Out